Lenaïg Le Clech

Years Active: 2017-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvie Tondeur, Franciane Paul, Jérémie Riou, Olivier Mansier, Dana Ranta, Lenaïg Le Clech, Eric Lippert, Suzanne Tavitian, Driss Chaoui, Mélanie Mercier, Benoit De Renzis, Laurane Cottin, Bruno Cassinat, Jean-Marie Chrétien, Jean-Christophe Ianotto, Olivier Allangba, Christophe Marzac, Laurent Voillat, Françoise Boyer, Corentin Orvain, Mathilde Hunault-Berger, François Girodon, Jean-Jacques Kiladjian, Valérie Ugo, Damien Luque Paz
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study. Leukemia 35 (3) (2020)
Lenaïg Le Clech, Jean-Philippe Talarmin, Marie-Anne Couturier, Jean-Christophe Ianotto, Christophe Nicol, Ronan Le Calloch, Stéphanie Dos Santos, Pascal Hutin, Didier Tandé, Virginie Cogulet, Christian Berthou, Gaëlle Guillerm
Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study. Infectious diseases (London, England) 50 (7) (2018)
Lenaïg Le Clech, Mehdi Sakka, Ahmed Meskar, Helene Kerspern, Jean-Richard Eveillard, Christian Berthou, Caroline Buors, Eric Lippert, Gaelle Guillerm, Isabelle Quintin-Roué, Jean-Luc Carré, Jean-Christophe Ianotto
The presence of monoclonal gammopathy in Ph-negative myeloproliferative neoplasms is associated with a detrimental effect on outcomes. Leukemia & lymphoma 58 (11) (2017)

Lenaïg Le Clech.css-eqlu8i{font-size:small;padding-left:4px;}